Effect of Different Water Injection Temperatures on the Safety and Comfort of Patients Undergoing Ultrasound Endoscopy of Small Probes Under Intravenous Anesthesia
1 other identifier
observational
270
1 country
1
Brief Summary
Miniprobe endoscopic ultrasonography (mEUS) is a key diagnostic modality for gastrointestinal (GI) mucosal or submucosal lesions, requiring water infusion to eliminate intraluminal air and improve image clarity. However, the optimal water temperature for sedated mEUS remains uncertain-previous studies suggest water temperature may affect GI peristalsis, haemodynamics, image quality, and patient safety/comfort, but no research has focused on this topic in sedated mEUS. This is a prospective, multicentre, double-blind, randomized controlled study. Eligible patients (≥18 years with GI mucosal/submucosal lesions requiring sedated mEUS) are randomly assigned to three groups based on water temperature: cold water (6-10 °C), warm water (20-24 °C), and hot water (35-39 °C). The primary objectives are to evaluate the effects of different water temperatures on mEUS image quality (standardized scoring) and diagnostic accuracy. Secondary outcomes include GI peristaltic grade, haemodynamic indices (measured at 6 time points), adverse events, and patient somatic/psychological feeling, comfort, and satisfaction scores. The study aims to identify the optimal water temperature that reduces GI peristalsis, improves mEUS diagnostic performance, and ensures patient safety and comfort during sedated mEUS, providing evidence for standardized clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2022
CompletedStudy Start
First participant enrolled
June 14, 2022
CompletedFirst Posted
Study publicly available on registry
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedDecember 26, 2025
July 1, 2022
11 months
June 12, 2022
December 19, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
mEUS image quality
Assessed by two independent experts (excluding the operating endoscopist) using Soon's scoring method on a 1-5 scale: 1 = air artifact obscures target lesion; 2 = air artifact severely impairs lesion size/characteristic assessment; 3 = air artifact mildly impairs lesion size/characteristic assessment; 4 = air artifact present but does not compromise lesion assessment; 5 = no air artifact with unimpaired lesion assessment. Scores 1-2 = poor, 3-4 = good, 5 = excellent.
From examination initiation through 24 hours post-examination
mEUS diagnostic accuracy
Gold standard confirmation: surgical, ESD or puncture histopathological results for patients with tissue specimens; ≥6-month clinical follow-up (based on manifestations, test results, lesion size and echogenic changes) for determining benign/malignant nature in other patients.
Up to 6 months after mEUS examination
Secondary Outcomes (4)
Gastrointestinal (GI) peristaltic grade
During mEUS examination
Haemodynamic indices
At T0, T1, T2, T3, T4, and T5 time points
Adverse events
Periprocedural (from anesthesia assessment to post-anesthesia wakefulness)
Somatic and psychological feeling scores
Post-anesthesia recovery (Day 1)
Study Arms (3)
Low temperature group
The temperature is 6℃-10℃.
room temperature group
The temperature is 20℃-24℃.
Core temperature group
The temperature is 35℃-39℃.
Interventions
Water injection is a routine procedure for endoscopy of small probe ultrasound, and our intervention is to change the water temperature and observe the effects of different water temperatures on patient safety and comfort.
Eligibility Criteria
In the Third Xiangya Hospital of Central South University, the First Affiliated Hospital of South China University, the South China Hospital Affiliated to the University of South China, the Hunan Provincial People's Hospital, and the First People's Hospital of Changde City, patients with small probe ultrasound endoscopy under intravenous anesthesia due to gastrointestinal bulge lesions.
You may qualify if:
- Age ≥ 18 years old;
- Gastrointestinal (GI) mucosal or submucosal lesions detected by general endoscopy;
- Require small-probe ultrasonic endoscopy (mEUS) under sedation for definitive diagnosis;
- Clearly understand the study and voluntarily participate, with informed consent provided.
You may not qualify if:
- Failure to meet the requirements for mEUS examination and anaesthesia, or need to use multiple sedative and analgesic drugs;
- Pregnancy or breastfeeding;
- Chronic use of opioids and benzodiazepines;
- Structural changes in the GI tract caused by abdominal surgery;
- Presence of mental illness;
- Presence of lesions in the oesophagus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
he Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
Study Officials
- STUDY CHAIR
L Tian
The Third Xiangya Hospital of Central South University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
June 12, 2022
First Posted
July 12, 2022
Study Start
June 14, 2022
Primary Completion
May 1, 2023
Study Completion
June 30, 2023
Last Updated
December 26, 2025
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.